Technology
Health
Biotechnology
Nabriva Therapeutics
$2.309876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$2.30
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
+$0.12 (5.56%) Today
+$0.02 (0.88%) As of 7:15 PM EDT after-hours
Why Robinhood?
You can buy or sell NBRV and other stocks, options, ETFs, and crypto commission-free!
About NBRV
Nabriva Therapeutics plc Ordinary Shares Ireland, also called Nabriva Therapeutics, is a clinical stage biopharmaceutical company, which engages in the research and development of novel antibiotics to treat serious infections. Its product pipeline includes Lefamulin, CONTEPO, and BC-7013. Read More The company was founded in October 2005 and is headquartered in Dublin, Ireland.
Employees
110
Headquarters
Dublin, Dublin
Founded
2005
Market Cap
167.26M
Price-Earnings Ratio
—
Dividend Yield
0.00
Average Volume
1.19M
High Today
$2.43
Low Today
$2.09
Open Price
$2.18
Volume
2.70M
52 Week High
$3.27
52 Week Low
$1.12
Collections
Technology
Health
Biotechnology
Therapy
Medical
Biopharmaceutical
Research And Development
Pharmaceutical
Price Paid on Robinhood
19% Lower
Right Now
52 Week Low
$1.12
Average Price Paid
$2.82
52 Week High
$6.05
Analyst Ratings
88%
of 8 ratings
Buy
88%
Hold
13%
Sell
0%
NBRV Earnings
-$0.79
-$0.62
-$0.46
-$0.29
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
—
Actual
-$0.30 per share